Home LiteratureArticle Details
PMID: 26344907 Published · ppublish English

PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche.

Stem cell reports ·Vol. 5 ·No. 4 ·2016-08-02

López-Ruano Guillermo, Prieto-Bermejo Rodrigo, Ramos Teresa L, San-Segundo Laura, Sánchez-Abarca Luis Ignacio, Sánchez-Guijo Fermín, Pérez-Simón José Antonio, Sánchez-Yagüe Jesús, Llanillo Marcial, Hernández-Hernández Ángel

Abstract

The regulation of hematopoietic stem cells (HSCs) depends on the integration of the multiple signals received from the bone marrow niche. We show the relevance of the protein tyrosine phosphatase PTPN13 and β-catenin as intracellular signaling molecules to control HSCs adhesiveness, cell cycling, and quiescence. Lethally irradiated mice transplanted with Lin(-) bone marrow cells in which PTPN13 or β-catenin had been silenced showed a significant increase of long-term (LT) and short-term (ST) HSCs. A decrease in cycling cells was also found, together with an increase in quiescence. The decreased expression of PTPN13 or β-catenin was linked to the upregulation of several genes coding for integrins and several cadherins, explaining the higher cell adhesiveness. Our data are consistent with the notion that the levels of PTPN13 and β-catenin must be strictly regulated by extracellular signaling to regulate HSC attachment to the niche and the balance between proliferation and quiescence.

Article Info
Journal
Stem cell reports
Abbr.
Stem Cell Reports
Published
2016-08-02
Indexed
2015-10-15
Updated
2015-11-20
Language
English
Country/Region
United States
NLM ID
101611300
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]